U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C14H17N5
Molecular Weight 255.3183
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of DESMETHYL RIZATRIPTAN

SMILES

CNCCC1=CNC2=C1C=C(CN3C=NC=N3)C=C2

InChI

InChIKey=HTVLSIBBGWEXCH-UHFFFAOYSA-N
InChI=1S/C14H17N5/c1-15-5-4-12-7-17-14-3-2-11(6-13(12)14)8-19-10-16-9-18-19/h2-3,6-7,9-10,15,17H,4-5,8H2,1H3

HIDE SMILES / InChI

Molecular Formula C14H17N5
Molecular Weight 255.3183
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

Patents

Patents

Substance Class Chemical
Created
by admin
on Sat Dec 16 08:10:35 GMT 2023
Edited
by admin
on Sat Dec 16 08:10:35 GMT 2023
Record UNII
OMH84Z34GP
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
DESMETHYL RIZATRIPTAN
Common Name English
N-METHYL-2-(5-(1H-1,2,4-TRIAZOL-1-YLMETHYL)-1H-INDOL-3-YL)ETHANAMINE
Systematic Name English
MONODESMETHYLRIZATRIPTAN
Common Name English
1H-INDOLE-3-ETHANAMINE, N-METHYL-5-(1H-1,2,4-TRIAZOL-1-YLMETHYL)-
Systematic Name English
RIZATRIPTAN BENZOATE IMPURITY I [EP IMPURITY]
Common Name English
Code System Code Type Description
FDA UNII
OMH84Z34GP
Created by admin on Sat Dec 16 08:10:35 GMT 2023 , Edited by admin on Sat Dec 16 08:10:35 GMT 2023
PRIMARY
PUBCHEM
10149236
Created by admin on Sat Dec 16 08:10:35 GMT 2023 , Edited by admin on Sat Dec 16 08:10:35 GMT 2023
PRIMARY
CAS
144034-84-4
Created by admin on Sat Dec 16 08:10:35 GMT 2023 , Edited by admin on Sat Dec 16 08:10:35 GMT 2023
PRIMARY
EPA CompTox
DTXSID70162604
Created by admin on Sat Dec 16 08:10:35 GMT 2023 , Edited by admin on Sat Dec 16 08:10:35 GMT 2023
PRIMARY
Related Record Type Details
PARENT -> METABOLITE
The mono N-desmethyl metabolite has intrinsic potency that is about 3-fold lower. Its contribution to in vivo efficacy is probably very low or negligible, since circulating concentrations are about one-tenth those of the parent drug
Related Record Type Details
PARENT -> IMPURITY
UNSPECIFIED
EP